Close Menu

University of British Columbia

The team will use DNA sequencing technology to study 12 forme fruste tumors that currently lack effective diagnostics and treatments.

A Canadian research team used a combination of real-time quantitative PCR and microfluidic technology to assess miRNA expression patterns in nearly 30 hematopoietic cell populations in adult mice.

The antibody profile could potentially be used to improve stratification of patient cohorts in clinical trials or as a point-of-care test to determine whether a patient needs vaccination, Reinhard Hiller, managing director of CPGR, told ProteoMonitor.

The technique allows for the first time the proteome-wide study of protein carboxy termini, according to one of its developers.

The recruitment effort seeks researchers to fill two new positions in metabolic engineering and synthetic biology; two new positions in computational tools and technology development; and two existing positions in chemical, molecular and systems biology, and bioengineering.

CPGR will be developing multiplex protein array-based antibody profiling assays and related bioinformatic analysis methods for the project with the ultimate aim of creating a biomarker signature that can be used for companion diagnostic purposes.

The partners aim to identify biomarkers that may predict how patients react to seasonal influenza vaccinations.

The algorithm, which was developed in collaboration with researchers in the Mathematics of Information Technology and Complex Systems groups at the University of British Columbia and Simon Fraser University, will allow Kinexus to do high-resolution mapping of an estimated 25 million kinase-substrate interactions, said a company official.

Genome British Columbia said today that a team comprising researchers from Canada, the US, and France is embarking on an effort to sequence and develop genetic tools for the sunflower genome.

The $3.2 million project funded by DOD and Canada will focus on using bacterial genomics to develop RDX degradation tools.

Pages

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.